Wellcome responds to closure of the Fleming Fund

Jeremy Knox, Head of Infectious Disease Policy at Wellcome, said: 

"The global response to antimicrobial resistance (AMR) is still not going far or fast enough to tackle this crisis. For the last decade, the Fleming Fund has been a flagship example of the UK’s global leadership on AMR. As with many areas of global health, cuts like these will be felt most acutely in countries in Africa and Asia. It also risks sending a signal that the UK is dialling back its commitment to global health efforts at a challenging moment.  

“The Fleming Fund has been instrumental in building our understanding of drug-resistant infections and their prevalence and trends worldwide. The world cannot afford to lose this progress. The UK must continue to make concerted efforts against growing global health challenges like AMR, through new and equitable partnerships in countries most affected.”